Rutgers COVID-19 Cohort Study

Completed

Conditions studied: Coronavirus, SARS-CoV-2

In brief

Our long-term goal is to protect the health care workforce (HCW) caring for SARS-CoV-2-infected patients, their families, communities, and the general population. Our specific objective is to rapidly establish a prospective cohort to characterize the factors related to viral transmission and disease severity in a large healthcare system. We addressed this hypothesis by recruiting and longitudinally following 546 HCW and a comparison group of 283 non-HCW within a large academic health system, Rutgers Biomedical and Health Sciences (RBHS). By intensively following participants over a several year period (2020-2024) and collecting serial biospecimens (nasopharyngeal/throat swabs, blood, and saliva) and questionnaire data at multiple time points, we will uniquely characterize SARS-CoV-2 transmission and risk factors for COVID-19 among HCW and our larger academic community.

Key facts

Study ID

NCT04336215

Run by

Rutgers, The State University of New Jersey

People needed

829

Starts

2020-04-07

Expected to finish

2024-08-31

Last updated by the study team

2026-05-15

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 20 years and older
• Hospital and RBHS healthcare workers who have regular direct patient contact (≥3 patients/shift) in emergency rooms or inpatient settings that is expected to continue regularly over the next ≥3 months and who work ≥20 hours in the hospital weekly (residents, clinical fellows, attending physicians, nurse practitioners, physician assistants, registered nurses, license practice nurses, medical technicians, respiratory therapists, physical therapists, clinical pharmacists, dentists, dental hygienists, or dental assistants)
• Hospital workers who do not have patient contact and non-healthcare from the Rutgers faculty, postdoctoral students, administrators, and staff.

You may not qualify if…

• Previous diagnosis with COVID-19
• Pregnant or have been diagnosed with a new medical condition in the past 30 days or have had a change in medications in the past 30 days
• Participants who have been hospitalized in the past 30 days, had and had an emergency room, urgent care visit, or have had surgery.
• Participants who have a fever on the day of their first visit to the study site (for consent, biospecimen collection, etc.).

Where it is running

• Clinical Research Center Rutgers-Robert Wood Johnson Medical School RWJUH East Tower - — New Brunswick, New Jersey, United States
• Robert Wood Johnson University Hospital — New Brunswick, New Jersey, United States
• Clinical Research Unit Rutgers New Jersey Medical School — Newark, New Jersey, United States
• Rutgers School of Dental Medicine — Newark, New Jersey, United States
• University Hospital — Newark, New Jersey, United States
• Environmental and Occupational Health Sciences Institute — Piscataway, New Jersey, United States
• RUCDR Infinite Biologics — Piscataway, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.